The Advocacy Exchange is the natural evolution of the COVID Advocacy Exchange (CAE), a first-of-its-kind platform offering live, interactive discussions through which patient voices are heard, and a virtual exhibit hall where participating organizations can share resources and learn from one another – all available free of charge, 24/7 at www.TheAdvocacyExchange.com.
While the pandemic and its effects continue to be felt, we are moving into a new chapter where we have the opportunity to expand and enhance the Exchange to best serve the advocacy community’s current and future needs. As such, we felt it was appropriate to remove the word “COVID” from the name of this platform to more accurately reflect the goal of this resource to support advocacy efforts, broadly.
Bristol Myers Squibb and GRYT Health are industry leaders connecting patient advocacy organizations in an innovative entirely virtual approach. GRYT Health is a digital oncology company with a social purpose who created both the Global Virtual Cancer Conference and the GRYT Health platform, which offers opportunities for connection and learning, paired with research, marketing and clinical trial services that put people and caregivers first. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
The Advocacy Exchange remains available to global and local patient advocacy organizations and members of their communities, spanning disease states.
Registration and access to the Advocacy Exchange are free.
The Advocacy Exchange offers the opportunity to participate in live virtual sessions, Working Group discussions, and provides free access to materials from Bristol Myers Squibb, patient advocacy organizations and third-party experts through the virtual exhibitor space, as well as the ability to view recordings of previous virtual sessions on-demand and connect with fellow advocates in a dedicated chatroom, 24/7. Additionally, the Advocacy Exchange features a newsroom and searchable resource library. Future planned enhancements to the platform include an opt-in member directory, “Ask an Advocate” forum, and a method to submit ideas/express interest in further involvement in the Exchange through the platform itself.
In ongoing collaboration with the global patient advocacy community, we plan to continue enhancing the Advocacy Exchange to create a lasting coalition and platform that exists for the long-term, covering critical topics of importance to the advocacy community.
The response from advocates has been overwhelmingly positive, with more than 200 people from 34 countries registering for the platform in the first two weeks alone. More than 100 attendees joined the first live virtual panel session, expressing gratitude for the platform and its efforts to unite the global advocacy community during this time of unprecedented challenges for all. Our community has since grown to more than 4,800 registered users from around the world, with more than 25,000 visitors from 95 countries.